What is the optimal way to subdivide obsessive-compulsive disorder?

被引:42
作者
de Mathis, Maria Alice
Diniz, Juliana Belo
do Rosario, Maria Conceicao
Torres, Albina R.
Hoexter, Marcelo
Hasler, Gregor
Miguel, Euripedes C.
机构
[1] Univ Sao Paulo, Sch Med, Dept Psychiat, BR-05403010 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil
[3] Univ Zurich Hosp, Dept Psychiat, Clin Affect Disorders, CH-8091 Zurich, Switzerland
关键词
SEROTONIN REUPTAKE INHIBITORS; CEREBRAL GLUCOSE-METABOLISM; BLOOD-FLOW ABNORMALITIES; FACTOR-ANALYZED SYMPTOM; 7-YEAR FOLLOW-UP; EARLY-ONSET; SPECTRUM DISORDERS; TOURETTES-SYNDROME; TREATMENT RESPONSE; RHEUMATIC-FEVER;
D O I
10.1017/S1092852900014899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The clinical presentation of obsessive-compulsive disorder (OCD) varies not only across patients but over the course of the disorder. This diversity indicates that OCD is a heterogeneous disorder, which may have an important impact on psychopathological, longitudinal, genetic, and treatment research. To better understand OCD heterogeneity, more homogeneous phenotypic descriptions are necessary to delimiting clinically meaningful subgroups of patients. Besides phenotypic descriptions, another method of delimiting OCD patient subgroups includes the search for endophenotypes (extended phenotypes) based on neurophysiological, immunological, genetic, neuropsychological, or neuroanatomic (neuroimaging) paradigms. This article will describe some strategies that deal with OCD heterogeneity, including the identification of more homogeneous phenotypical categories, an improved understanding of obsessive-compulsive symptom dimensions and how to use them as quantitative traits, and broadening the diagnostic boundaries of OCD to include other related conditions. The relevance and limitations of each approach are also discussed. Since the etiological mechanisms associated with the expressions of OCD are unknown, there is probably not one but several heuristic strategies to search for more homogeneous OCD subgroup, that combined may provide the most fruitful results.
引用
收藏
页码:762 / +
页数:15
相关论文
共 178 条
[1]   Deep brain stimulation for refractory obsessive-compulsive disorder [J].
Abelson, JL ;
Curtis, GC ;
Sagher, O ;
Albucher, RC ;
Harrigan, M ;
Taylor, SF ;
Martis, B ;
Giordani, B .
BIOLOGICAL PSYCHIATRY, 2005, 57 (05) :510-516
[2]   Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder [J].
Abramowitz, JS ;
Franklin, ME ;
Schwartz, SA ;
Furr, JM .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2003, 71 (06) :1049-1057
[3]   Side effects as predictors of drug response in obsessive-compulsive disorder [J].
Ackerman, DL ;
Greenland, S ;
Bystritsky, A .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) :459-465
[4]  
ACKERMAN DL, 1994, J CLIN PSYCHOPHARM, V14, P247
[5]   Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder [J].
Ackerman, DL ;
Greenland, S ;
Bystritsky, A .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (03) :185-192
[6]  
ALARCON RD, 1993, J CLIN PSYCHOPHARM, V13, P210
[7]  
Albert Umberto, 2002, Epidemiol Psichiatr Soc, V11, P116
[8]   Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy [J].
Alonso, P ;
Menchon, JM ;
Pifarre, J ;
Mataix-Cols, D ;
Torres, L ;
Salgado, P ;
Vallejo, J .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (07) :535-540
[9]  
Alsobrook JP, 1999, AM J MED GENET, V88, P669, DOI 10.1002/(SICI)1096-8628(19991215)88:6<669::AID-AJMG17>3.0.CO
[10]  
2-N